Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Evolent HealthFRA:9EH +3.06%63 Market Cap is €586 Mil as of Jul. 21, 2026. GuruFocus rates FRA:9EH with a GF Score™ of 63/100 and a GF Value™ of €9.69 (Possible Value Trap). The stock has 7 warning signs investors should review. Among 695 Healthcare Providers & Services companies, Evolent Health ranks better than 75.68% on this metric.
Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Evolent Health's share price for the quarter that ended in Mar. 2026 was €1.89. Evolent Health's Shares Outstanding (EOP) for the quarter that ended in Mar. 2026 was 112 Mil. Therefore, Evolent Health's market cap for the quarter that ended in Mar. 2026 was €213 Mil.
Evolent Health's quarterly market cap
declined
from Sep. 2025 (€826 Mil) to Dec. 2025 (€382 Mil) and
declined
from Dec. 2025 (€382 Mil) to Mar. 2026 (€213 Mil).
Evolent Health's annual market cap
declined
from Dec. 2023 (€3,439 Mil) to Dec. 2024 (€1,219 Mil) and
declined
from Dec. 2024 (€1,219 Mil) to Dec. 2025 (€382 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Evolent Health's Enterprise Value for Today is €1,326 Mil.
Evolent Health (FRA:9EH) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
Evolent Health Market Cap Related Terms
Evolent Health Market Cap Historical Data
* Premium members only.
The historical data trend for Evolent Health's Market Cap can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Health Information Services subindustry, Evolent Health's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Evolent Health Market Cap vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Evolent Health's Market Cap distribution charts can be found below:
* The bar in red indicates where Evolent Health's Market Cap falls into.
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
Evolent Health's Market Cap for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Evolent Health (FRA:9EH) has a Market Cap of €586 Mil as of Jul. 21, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Evolent Health and its competitors. According to the industry distribution chart, Evolent Health ranks #169 out of 695 companies in the Healthcare Providers & Services industry, placing it in the top 24.3%.
Is Evolent Health's Market Cap too high?
Evolent Health's current Market Cap is €586 Mil. Based on the distribution chart, Evolent Health ranks #169 out of 695 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, Evolent Health has a GF Score™ of 63/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Evolent Health's Market Cap compare to PHR and CTEV?
According to the Healthcare Providers & Services industry distribution chart, Evolent Health ranks #169 out of 695 companies for Market Cap. This places Evolent Health in the top 24% of its industry — outperforming the majority of peers. The industry median Market Cap is 103.63. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Healthcare Providers & Services company?
The median Market Cap among Healthcare Providers & Services companies is 103.63, based on 695 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Evolent Health and its competitors. For the Healthcare Providers & Services industry, the median Market Cap is 103.63 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Evolent Health's current Market Cap is €586 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Evolent Health stock overvalued right now?
Based on GuruFocus' analysis, Evolent Health (FRA:9EH) is currently considered Possible Value Trap. The stock's GF Value™ is €9.69, compared to a current price of €5.05 — trading 47.9% below its estimated fair value. The current Market Cap is €586 Mil. Evolent Health's overall GF Score™ is 63/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For Evolent Health (FRA:9EH), the current Market Cap is €586 Mil as of Jul. 21, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Evolent Health (FRA:9EH) Overvalued in 2026?
Based on GuruFocus' analysis, Evolent Health stock appears to be undervalued.
The current stock price of €5.05 is trading 47.9% below its estimated GF Value™ of €9.69.
GuruFocus considers Evolent Health to be Possible Value Trap.
Key valuation signals for FRA:9EH:
Market Cap: €586 Mil
GF Value™: €9.69 vs. price of €5.05 (47.9% below fair value)
No single metric tells the full story. See the FRA:9EH stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Evolent Health Inc is engaged in healthcare delivery and payment. The company supports health systems and physician organizations in their migration toward value-based care and population health management. It provides specialty care management services in oncology, cardiology, musculoskeletal markets and holistic total cost of care management along with an integrated platform for health plan administration and value-based business infrastructure under one go to market package. The solutions provided by the company includes: Oncology, Cardiology, Musculoskeletal, Administrative Services, Advanced Illness, Genetic Testing, Physical Medicine, Radiology, and Surgical Management.
63GF Score
Get the complete analysis for FRA:9EH
Market Cap is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:9EH has been successfully added to your 
